Alexander J Eustace

16PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyCancer diagnosisPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Dec 20, 2025
Chromosome centromere copy number amplification associated with exceptional response in HER2-positive metastatic breast cancer patients.

Charlotte Andrieu, Jojanneke Stoof, Dalal AlSultan

|Jun 05, 2025
TCHL - a phase II neo-adjuvant study assessing TCH (docetaxel, carboplatin and trastuzumab) and TCHL (docetaxel, carboplatin, trastuzumab and lapatinib) in HER-2 positive breast cancer patients: a 5-year follow-up with serum biomarker analysis.

John Crown, Alex J Eustace, Denis M Collins

|May 14, 2025
Translating Basic Science Discoveries into Clinical Advances: Highlights from the EACR-AACR-IACR 2024 Conference in Celebration of Irish Association for Cancer Research's 60th Anniversary.

Seodhna M Lynch, Cathy E Richards, Aisling Ui Mhaonaigh

|Jun 19, 2024
Precision Oncology, Artificial Intelligence, and Novel Therapeutic Advancements in the Diagnosis, Prevention, and Treatment of Cancer: Highlights from the 59th Irish Association for Cancer Research (IACR) Annual Conference.

Seodhna M Lynch, Aisling B Heeran, Caoimbhe Burke

|Jan 11, 2024
CARBON DOTS: Bioimaging and Anticancer Drug Delivery.

Michał Bartkowski, Yingru Zhou, Mustafa Nabil Amin Mustafa

|Sep 27, 2023
Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer.

Nicola Cosgrove, Alex J Eustace, Peter O'Donovan

Pageof 3

Frequent Collaborators

2 joint publications

Sinead Toomey

2 joint publications

Seodhna M Lynch

1 joint publications

Naomi Elster

1 joint publications

Kathy Gately